Online HML - June 2022


You are viewing June 2022. View May 2022 Schedule.

Monoclonal Antibodies
Bevacizumab Inj 25 mg per ml, 4 ml vial; Inj 25 mg per ml, 16 ml vial
Ranibizumab Inj 10 mg per ml, 0.23 ml vial; Inj 10 mg per ml, 0.3 ml vial
Infliximab Inj 100 mg
Tocilizumab Inj 20 mg per ml, 4 ml vial; Inj 20 mg per ml, 10 ml vial; Inj 20 mg per ml, 20 ml vial
Omalizumab Inj 150 mg prefilled syringe; Inj 150 mg vial
Siltuximab Inj 100 mg vial; Inj 400 mg vial
Obinutuzumab Inj 25 mg per ml, 40 ml vial
Pertuzumab Inj 30 mg per ml, 14 ml vial
Cetuximab Inj 5 mg per ml, 20 ml vial; Inj 5 mg per ml, 100 ml vial
Aflibercept Inj 40 mg per ml, 0.1 ml vial
Secukinumab Inj 150 mg per ml, 1 ml prefilled syringe
Trastuzumab emtansine Inj 100 mg vial; Inj 160 mg vial
Rituximab (riximyo) Inj 10 mg per ml, 10 ml vial; Inj 10 mg per ml, 50 ml vial
Mepolizumab Inj 100 mg prefilled pen; Inj 100 mg vial
Casirivimab and imdevimab Inj 120 mg per ml casirivimab, 11.1 ml vial (1) and inj 120 mg per ml imdevimab, 11.1 ml vial (1)
Adalimumab (Amgevita) Inj 20 mg per 0.4 ml prefilled syringe; Inj 40 mg per 0.8 ml prefilled pen; Inj 40 mg per 0.8 ml prefilled syringe
Palivizumab Inj 100 mg per ml, 1 ml vial
Basiliximab Inj 20 mg vial
Rituximab (mabthera) Inj 10 mg per ml, 10 ml vial; Inj 10 mg per ml, 50 ml vial
Trastuzumab Inj 150 mg vial; Inj 440 mg vial
Adalimumab (Humira) Inj 20 mg per 0.4 ml syringe; Inj 40 mg per 0.8 ml pen; Inj 40 mg per 0.8 ml syringe
Abciximab Inj 2 mg per ml, 5 ml vial